Key Transdermal Drug Delivery System Market Players:
- Novartis AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson
- Mylan Pharmaceuticals, Inc.
- Boehringer Ingelheim GmbH
- 3M Company
- Noven Pharmaceuticals, Inc.
- 4P Therapeutics, LLC
- Grünenthal
- AbbVie
Key companies in the transdermal drug delivery systems market are driving innovation through advancements in technologies such as microneedles, iontophoresis, and smart patches. These advancements are revolutionizing how drugs are delivered, offering improved absorption efficiency and better patch adhesion while expanding the range of drugs that can be administered transdermally. A notable example is Adlarity, a transdermal patch for Alzheimer’s disease launched by Corium Inc. in September 202. These innovations are making transdermal systems more effective, versatile, and accessible to patients worldwide These key players include:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of transdermal drug delivery system is evaluated at USD 43.78 billion.
Transdermal Drug Delivery System Market size was over USD 39.77 billion in 2025 and is projected to reach USD 114.98 billion by 2035, witnessing around 11.2% CAGR during the forecast period i.e., between 2026-2035.
North America commands a 47.60% share in the Transdermal Drug Delivery System Market, fueled by regulatory support and rising preference for non-invasive treatments, fostering robust growth by 2035.
Key players in the market include Johnson & Johnson, Mylan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, 3M Company.
